Statera Biopharma Inc (STAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Sales | 3,518 | 2,708 | 3,702 | 8,488 | 3,571 |
| Gross Profit | 3,518 | 2,708 | 3,702 | 8,488 | 3,571 |
| Operating Expenses | 9,874 | 13,499 | 18,124 | 31,565 | 33,617 |
| Operating Income | -6,356 | -10,791 | -14,422 | -23,077 | -30,047 |
| Interest Expense | 0 | 100 | 1,090 | 0 | 0 |
| Other Income | 3,766 | -2,154 | 15,547 | 2,948 | 7,632 |
| Pre-tax Income | -2,590 | -13,045 | 35 | -20,129 | -22,415 |
| Net Income Continuous | -2,590 | -13,045 | 35 | -20,129 | -22,415 |
| Minority Interests | 69 | -407 | -1,594 | -2,866 | -4,181 |
| Net Income | $-2,659 | $-12,638 | $1,629 | $-17,263 | $-18,234 |
| EPS Basic Total Ops | -0.24 | -1.79 | 0.60 | -7.67 | -9.75 |
| EPS Basic Continuous Ops | -0.24 | -1.85 | 0.01 | -8.95 | -11.99 |
| EPS Diluted Total Ops | -0.24 | -1.79 | 0.60 | -7.67 | -9.75 |
| EPS Diluted Continuous Ops | -0.24 | -1.85 | 0.01 | -8.95 | -11.99 |
| EPS Diluted Before Non-Recurring Items | -0.24 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-6,292 | $-10,516 | $-13,581 | $-22,606 | $-29,567 |